| Protocol | Title |
|---|---|
| E1405 | Phase II Study of VcR-CVAD with Rituximab Maintenance for Untreated
Mantle Cell Lymphoma
Activation Date: 01-may-2007 ECOG Participants(requires Adobe Acrobat) |
| E2402 | A Phase II Study of Cyclosporine in the Treatment of
Angioimmunoblastic T-Cell Lymphoma
Activation Date: 02-sep-2005 ECOG Participants(requires Adobe Acrobat) |
| E2404 | Bevacizumab and CHOP (A-CHOP) in Combination for Patients with
Peripheral T-Cell or Natural Killer Cell Neoplasms
Activation Date: 07-jul-2006 ECOG Participants(requires Adobe Acrobat) |
| E3402 | A Phase II Trial of R-CHOP Followed by Zevalin Radioimmunotherapy for
Patients with Previously Untreated Stages I and II CD20+ Diffuse
Large Cell Non-Hodgkin's Lymphoma
Activation Date: 10-dec-2004 ECOG Participants(requires Adobe Acrobat) |
| E3404 | Response-Adapted Therapy for Aggressive non-Hodgkin's Lymphomas based
on early [18F] FDG-PET Scanning
Activation Date: 07-apr-2006 ECOG Participants(requires Adobe Acrobat) |
| E4402 | Randomized Phase III Trial Comparing Two Different Rituximab Dosing
Regimens for Patients with Low Tumor Burden Indolent non-Hodgkin's
Lymphoma
Activation Date: 21-nov-2003 |
| S0016 | A Phase III Trial of CHOP + Rituximab vs CHOP + Iodine-131-Labeled
Monoclonal Anti-B1 Antibody (Tositumomab) For Treatment of Newly
Diagnosed Follicular Non-Hodgkin's Lymphomas
Activation Date: 08-mar-2006 |
All contents copyright © 1998 Eastern Cooperative Oncology Group.
All rights reserved.
Revised: 07/05/08